INLX has only a single published analyst price target, making a meaningful multi-analyst average impossible. Howard Halpern of Taglich Brothers carries a $14.50 target with an Outperform-style rating. That figure is far above both the current price and the stock's 52-week high of $9.30, and it represents a single, notably optimistic view rather than a consensus.
Because the minimum of multiple credible, current analyst targets is not available, the $5.30 central target here is drawn from public discussion instead. Independent valuation commentary, including InvestingPro's fair-value estimate of approximately $5.34, points to a level meaningfully above the latest quote without relying on a lone analyst's aggressive projection. This is stated plainly as a fallback target, not an official published consensus. From what I see, this approach keeps expectations grounded.
The stock last closed at $3.82, near the bottom of its 52-week range of $3.77 to $9.30. Reaching $5.30 implies a 38.7% advance — a substantial move that would require the shares to first reclaim recent trading levels around $4.00 to $4.40 and then clear the $5.00 psychological level.
Fundamentally, Intellinetics is a small but established operator with roughly $16.2 million in trailing revenue and a negative net margin. The company is prioritizing SaaS-led recurring revenue and margin improvement under CEO Alison Forsythe, appointed in February 2026, but it has not yet reached sustained profitability. A path toward $5.30 would most plausibly depend on improved revenue visibility and evidence of narrowing losses, which could support a re-rating of a stock currently trading near 1.1 times trailing sales. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The stock's most durable technical reference points are its 52-week high of $9.30 and its 52-week low of $3.77, the latter essentially current price. Nearby support sits around $3.77, with a secondary zone near the round $3.50 level. On the upside, resistance appears first in the $4.00 to $4.44 band where the shares traded in early November, followed by the psychologically important $5.00 level, which coincides closely with the central target. A sustained move above $5.00 would represent a meaningful change in market structure after a long decline.
Analyst price targets and fair-value estimates generally reflect a roughly 12-month forward horizon, though no specific horizon is documented for this thinly covered name. The single analyst target of $14.50 implies a far more aggressive expectation than the independent fair-value figure near $5.34. The next confirmed earnings report is scheduled for November 12, 2026, and investors should watch revenue mix, gross margin, and the pace of cash losses. Also relevant are any new analyst initiations or target revisions, insider activity, and the company's progress toward sustained profitability. I'm watching this closely ahead of the report.
In my own research process, I turn to Tickeron's AI Daily Buy/Sell Signals to monitor momentum shifts in names like this. The tool applies artificial intelligence to thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on technical behavior and market conditions. For a low-liquidity micro-cap such as INLX, it helps surface changes more efficiently than manual checks alone. Traders can use it to track positions and spot emerging structure shifts. This fits naturally into a broader workflow when evaluating recovery scenarios.
Can INLX reach $5.30? The question rests on a fallback target derived from independent valuation commentary rather than an analyst consensus, because the stock carries only one published price target. Reaching $5.30 would require a roughly 39% gain from $3.82 — a substantial move that hinges on evidence of a stabilizing, increasingly recurring revenue base and narrowing losses. Supportive factors include a low sales multiple and insider buying, while persistent losses, thin liquidity, and a long downtrend are the principal obstacles. The lone analyst's $14.50 target underscores how divergent views can be on this micro-cap. Investors should focus on the November earnings report, margin trends, and any new analyst coverage or revisions before drawing conclusions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +1.98% 3-day Advance, the price is estimated to grow further. Considering data from situations where INLX advanced for three days, in 147 of 202 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
INLX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on INLX as a result. In 82 of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.
The Moving Average Convergence Divergence Histogram (MACD) for INLX turned negative on October 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 41 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 80%.
INLX moved below its 50-day moving average on October 09, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where INLX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 23 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.752) is normal, around the industry mean (-1.906). P/E Ratio (-5.969) is within average values for comparable stocks, (9.554). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.069) among similar stocks. P/S Ratio (1.389) is also within normal values, averaging (70.383).
The Tickeron Price Growth Rating for this company is 85 (best 1 - 100 worst), indicating slightly worse than average price growth. INLX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INLX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry PackagedSoftware